Newsletter | November 18, 2020

11.18.20 -- CDMO Oversight In Biomanufacturing

Mitigating Risks Associated With Single-Use Systems: Critical Considerations

If you plan to utilize a single-use system for your product manufacturing, there are specific factors that must be considered, all of which play important roles in determining your project’s total risk profile.

Best Practices For Biopharmaceutical Technology Transfer: Facility Fit And Process Gap Assessments

During a long, complex journey of drug discovery, with many specialized activities involved, technology transfer is an intrinsic part of the successful development, manufacturing, and commercialization of a product. Biopharmaceutical technology transfer requires careful planning and evaluation to meet project timelines for scale-up and GMP manufacture.

Choose A CDMO Partner That Integrates Market Intelligence For Aseptic Fill And Finish
Today, a plethora of contract development and manufacturing organizations (CDMOs) provide aseptic fill/finish services around the world. However, to offer customers both favorable outcomes and exceptional value, a CDMO must make the curation and integration of deep market intelligence a core part of its service offering.
What You Should Know About Cell Line Development To Ensure A Successful Launch

Effective, strategic cell line development positions your product for regulatory and commercial success. When it comes time to develop your cell lines, here are the crucial factors to consider.

Fully Integrated CMO, CDO, And CRO Services

Samsung Biologics is a reliable partner for seamless tech transfers, clinical and commercial manufacturing, aseptic fill/finish, and analytical testing. From the very beginning of our partnership you will have a dedicated project management team to walk you through the entire journey of the development and manufacturing of your product. We are committed to operational excellence in cGMP manufacturing and quality assurance to deliver value to our clients.

Request Information